Shukra Pharma Board Meeting Rescheduled to Nov 4

Shukra Pharmaceuticals Ltd has announced a revision to its upcoming Board Meeting. The meeting, originally scheduled for November 3, 2026, has been rescheduled to November 4, 2026. The board will convene at the company's registered office to consider and approve the unaudited financial results for the second quarter and half-year ended September 30, 2026, along with the Auditor's Limited Review Report. The meeting will also address any other business with the Chairman's permission.